Mutations in PI3K catalytic subunit genes, especially p110α (PIK3CA), were frequently identified in prostate cancer with concurrent PIK3CA mutation and loss of phosphatase and tensin homolog (PTEN) accelerating tumorigenesis and promoting CRPC in mouse models [13]. Here, PIK3CD is linked to prostate carcinoma.